Protein aggregates and damaged organelles are tagged with ubiquitin chains to trigger selective autophagy. To initiate mitophagy, the ubiquitin kinase PINK1 phosphorylates ubiquitin to activate the ubiquitin ligase parkin, which builds ubiquitin chains on mitochondrial outer membrane proteins, where they act to recruit autophagy receptors. Using genome editing to knockout five autophagy receptors in HeLa cells, here we show that two receptors previously linked to xenophagy, NDP52 and optineurin, are the primary receptors for PINK1-and parkin-mediated mitophagy. PINK1 recruits NDP52 and optineurin, but not p62, to mitochondria to activate mitophagy directly, independently of parkin. Once recruited to mitochondria, NDP52 and optineurin recruit the autophagy factors ULK1, DFCP1 and WIPI1 to focal spots proximal to mitochondria, revealing a function for these autophagy receptors upstream of LC3. This supports a new model in which PINK1-generated phospho-ubiquitin serves as the autophagy signal on mitochondria, and parkin then acts to amplify this signal. This work also suggests direct and broader roles for ubiquitin phosphorylation in other autophagy pathways.
Protein aggregates and damaged organelles are tagged with ubiquitin chains to trigger selective autophagy. To initiate mitophagy, the ubiquitin kinase PINK1 phosphorylates ubiquitin to activate the ubiquitin ligase parkin, which builds ubiquitin chains on mitochondrial outer membrane proteins, where they act to recruit autophagy receptors. Using genome editing to knockout five autophagy receptors in HeLa cells, here we show that two receptors previously linked to xenophagy, NDP52 and optineurin, are the primary receptors for PINK1-and parkin-mediated mitophagy. PINK1 recruits NDP52 and optineurin, but not p62, to mitochondria to activate mitophagy directly, independently of parkin. Once recruited to mitochondria, NDP52 and optineurin recruit the autophagy factors ULK1, DFCP1 and WIPI1 to focal spots proximal to mitochondria, revealing a function for these autophagy receptors upstream of LC3. This supports a new model in which PINK1-generated phospho-ubiquitin serves as the autophagy signal on mitochondria, and parkin then acts to amplify this signal. This work also suggests direct and broader roles for ubiquitin phosphorylation in other autophagy pathways.
Selective autophagy clears intracellular pathogens and mediates cellular quality control by engulfing cargo into autophagosomes and delivering it to lysosomes for degradation. Autophagy receptors bind ubiquitinated cargo and LC3-coated phagophores to mediate autophagy 1, 2 . Damaged mitochondria are removed by autophagy after activation of the kinase PINK1 and the E3 ubiquitin ligase parkin (encoded by PARK2 in humans) 3, 4 . After the loss of mitochondrial membrane potential or the accumulation of misfolded proteins, PINK1 is stabilized on the outer mitochondrial membrane 3 , where it phosphorylates ubiquitin at Ser65 to activate parkin ubiquitin ligase activity [5] [6] [7] . Although the autophagy receptors p62 and optineurin (OPTN) have been shown to bind ubiquitin chains on damaged mitochondria, their roles, and the roles of the other autophagy receptors in mediating mitophagy, are unclear [8] [9] [10] [11] .
Autophagy receptors in mitophagy
To clarify autophagy receptor function during mitophagy, genome editing was used to knock out five autophagy receptors (designated pentaKO) in HeLa cells, which do not express endogenous parkin. DNA sequencing (Supplementary Table 1 ) and immunoblotting of TAX1BP1, NDP52 (also known as CALCOCO2), NBR1, p62 (SQSTM1) and OPTN (Fig. 1a , lane 6) confirmed their knockout. We analysed mitophagy in pentaKOs by measuring the degradation of cytochrome C oxidase subunit II (COXII), a mitochondrial DNA (mtDNA)-encoded inner membrane protein, after mitochondrial damage with oligomycin and antimycin A. After oligomycin and antimycin A treatment, COXII was degraded in wild-type cells expressing parkin, but not in pentaKOs or ATG5 knockout HeLa cells, indicating a block in mitophagy (Fig. 1b, c , Supplementary  Table 1 and Extended Data Fig. 1a ). As a second indicator of mitophagy, mtDNA nucleoids were quantified by immunofluorescence (Extended Data Fig. 1b ). After 24 h of oligomycin/antimycin A treatment, wild-type cells were nearly devoid of mtDNA, whereas mtDNA was retained in pentaKOs and ATG5 knockouts ( Fig. 1d, e ). Parkin translocated to mitochondria (Extended Data Fig. 1c ), and MFN1 and TOM20 (also known as TOMM20) were degraded via the proteasome comparably in wild-type and pentaKOs ( Fig. 1b and Extended Data Fig. 1d ). mtDNA nucleoids clump after oligomycin and antimycin A treatment in ATG5 knockout cells, but not in pentaKOs, consistent with a reported role of p62 (refs 10, 11) .
The five endogenous receptors in wild-type cells (Extended Data Fig. 1c ) and each receptor re-expressed in pentaKOs (Extended Data Fig. 1e , f) translocated to mitochondria after oligomycin/antimycin A treatment. However, in pentaKOs, only green fluorescent protein (GFP)-tagged NDP52, GFP-OPTN and, to a lesser extent, GFP-TAX1BP1 rescued mitophagy ( Fig. 1f, g) . Another recently reported autophagy receptor, TOLLIP 12 , neither recruited to mitochondria nor rescued mitophagy after oligomycin/antimycin A treatment (Extended Data Fig. 1g -i).
We generated OPTN and NDP52 single knockout, NDP52/OPTN double knockout (DKO), and NDP52/OPTN/TAX1BP1 triple knockout cell lines ( Supplementary Table 1 and Fig. 1a ), and found no compensatory change in the expression of the remaining receptors. NDP52 or OPTN knockout alone caused no defect in mitophagy, whereas the NDP52/OPTN DKO and to a greater extent the NDP52/OPTN/TAX1BP1 triple knockout inhibited mitophagy ( Fig. 2a-d and Extended Data Fig. 2a, b) . The robust mitophagy observed in OPTN knockouts contrasts with a report indicating loss of mitophagy using RNA interference (RNAi)-mediated knockdown of OPTN in HeLa cells 9 . Although NDP52 and OPTN redundantly mediate mitophagy, they function non-redundantly in xenophagy 13 . Their expression levels in human tissues indicate that OPTN or NDP52 may function more prominently in different tissues (Extended Data Fig. 2c ).
Mutations in autophagy receptors can lead to diseases such as primary open angle glaucoma (OPTN; E50K) 14 , amyotrophic lateral sclerosis (OPTN; E478G and Q398X, in which X denotes a stop codon) 15 and Crohn's disease (NDP52; V248A) 16 . Defects in xenophagy occur when OPTN is mutated to block its phosphorylation by TANK-binding kinase 1 (TBK1; S177A) or its ubiquitin binding (D474N) 13, 17 . In pentaKOs, the UBAN domain-disrupting mutants OPTN (Q398X), OPTN(D474N) and OPTN(E478G) (Extended Data Fig. 2d ) failed to translocate to mitochondria (Extended Data Fig. 2e , f) or rescue mitophagy ( Fig. 2e and Extended Data Fig. 2g ). OPTN(S177A) weakly rescued mitophagy and minimally translocated to mitochondria, whereas OPTN(E50K) robustly translocated and substantially rescued mitophagy ( Fig. 2e and Extended Data Fig. 2e -g). NDP52(V248A) fully recruited to mitochondria and rescued mitophagy, but a mutant lacking the zinc-finger ubiquitinbinding domains (NDP52(DZF)) 18 did not (Extended Data Fig. 2h -k and Fig. 2f ). Thus, ubiquitin binding by OPTN and NDP52 is necessary for mitophagy, and some disease-causing mutations prevent mitophagy.
TBK1 and OPTN cooperate in mitophagy TBK1 phosphorylation of OPTN at Ser177 increases its association with LC3 during xenophagy 13 , and the OPTN(E50K) mutation increases TBK1 and OPTN binding 19 . TBK1 auto-phosphorylation at Ser172 is indicative of TBK1 activation 20 and occurs in a parkindependent manner after 3 h of oligomycin/antimycin A treatment, but only in cells expressing OPTN (Extended Data Fig. 3b , lanes 4 and 10). Prolonged oligomycin and antimycin A treatment induces moderate TBK1 phosphorylation in the absence of parkin, but still requires PINK1 (Extended Data Fig. 3c ). To investigate TBK1 function during mitophagy, we generated TBK1 knockout, and TBK1/NDP52 and TBK1/OPTN DKO HeLa cells (Extended Data Fig. 3d and Supplementary Table 1 ). Parkin translocated to mitochondria in all cell lines, however, only TBK1/NDP52 DKOs displayed defective mitophagy (Extended Data Fig. 3e and Fig. 2g -j). Mitophagy in TBK1/NDP52 DKOs was rescued by wild-type TBK1 or phosphomimetic OPTN (OPTN(S177D)), but not by kinase-dead TBK1 (TBK1(K38M); Extended Data Fig. 3g -i). Thus, in the absence of NDP52, TBK1 is crucial for effective mitophagy via OPTN.
Ubiquitin phosphorylation in mitophagy
Although many autophagy receptors recruit to the mitochondria after parkin activation, it is unclear why only some of these function in mitophagy. Parkin-mediated mitophagy is driven by the PINK1 phosphorylation of Ser65 of both ubiquitin [5] [6] [7] 21, 22 and the parkin UBL domain 23 . Because Ser65 phospho-ubiquitin is structurally unique, it may differentially interact with ubiquitin-binding proteins 22 . To determine whether OPTN is directly recruited to phospho-ubiquitin on mitochondria, we conditionally expressed PINK1 on undamaged mitochondria 10 in HeLa cells lacking parkin ( Fig. 3a and Extended Data Fig. 4a ). When PINK1D110-YFP-23FKBP (in which PINK1 lacks its N-terminal targeting sequence and is fused with yellow fluorescent protein (YFP) and two tandem FKBP domains at the C terminus) is cytosolic, mCherry-tagged OPTN (mCherry-OPTN), mCherry-NDP52 and mCherry-p62 are also cytosolic (Extended Data Fig. 4b , c). After rapalog treatment, PINK1D110-YFP-23FKBP localizes to mitochondria expressing the FKBP12/rapamycin-binding (FRB)-Fis1 targeting construct where ubiquitin on mitochondrial surface proteins 24 (Extended Data Fig. 4a ) can then be phosphorylated 5, 21, 25, 26 . This recruits OPTN and NDP52 to mitochondria ( Fig. 3a, b ), but not p62 ( Fig. 3b and Extended Data Fig. 4c ). OPTN and NDP52 recruitment requires PINK1 kinase activity ( Fig. 3a, b ) and receptor-ubiquitin binding, as the OPTN(D474N) and NDP52(DZF) mutants fail to recruit after rapalog treatment ( Fig. 3b and Extended Data Fig. 4d, e ). Therefore, the ubiquitin kinase activity of PINK1 recruits OPTN and NDP52 to mitochondria via ubiquitin-binding domains in the absence of parkin.
To determine whether the observed autophagy receptor recruitment to mitochondria in the absence of parkin can induce mitophagy, we developed a sensitive fluorescence-activated cell sorting (FACS)based mitophagy assay. We expressed mitochondrial-targeted mKeima (mt-mKeima, see Methods) in wild-type and pentaKO cells also expressing mitochondrial FRB-Fis1 and PINK1D110-YFP-23FKBP. mt-mKeima engulfment into lysosomes results in a spectral shift owing to low pH. Only 1% (range 0.89-1.15) of wild-type or pentaKO cells display mitophagy when PINK1 is cytosolic. However, when PINK1 is recruited to mitochondria with rapalog, mitophagy increases ,sevenfold in wild-type cells and ,eightfold with overexpressed OPTN ( Table 1 and Extended Data Fig. 5a ). PentaKO cells showed no increase in mitophagy after targeting PINK1 to mitochondria ( Table 1 and Extended Data Fig. 5b ). When rescued with Flag/ haemagglutinin (HA)-tagged OPTN or NDP52, pentaKOs displayed an increase in mitophagy of more than fivefold or fourfold, respectively (Table 1 and Extended Data Fig. 5b-e ). Rescue with Flag/HA-p62 or ubiquitin-binding mutants (OPTN(Q398X), OPTN(D474N) and NDP52 (DZF)) failed to increase mitophagy above baseline, but , and pentaKO (NDP52/OPTN/TAX1BP1/NBR1/p62) HeLa cells were confirmed by immunoblotting (IB). kDa, kilodaltons. b, c, Cells as indicated with or without mCherry (mCh)-parkin were analysed by immunoblotting (b), and COXII levels were quantified (c). d, e, Representative images of mCh-parkin-expressing wild-type, pentaKO and ATG5 knockout cells immunostained to label mtDNA (green) (d), and quantified for mitophagy (24 h oligomycin/antimycin A (OA)) (e). More than 75 cells were counted per sample. DAPI, 49,6-diamidino-2-phenylindole. Scale bars, 10 mm. f, g, Lysates from pentaKO cells expressing mCh-parkin and GFP-tagged autophagy receptors were immunoblotted (f) and COXII levels were quantified (g). Data in c, e and g are mean 6 s.d. from three independent experiments. ***P , 0.001 (one-way analysis of variance (ANOVA)). 
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G2015 Macmillan Publishers Limited. All rights reserved other mutants (OPTN(E50K), OPTN(S177A) and NDP52(V248A)) rescued mitophagy (Table 1 and Extended Data Fig. 5c-f ). OPTN(E50K) and OPTN(S177A) restored mitophagy as well as or better than wild-type OPTN (Table 1) , differing from their response in the presence of parkin ( Fig. 2e ), probably owing to the lack of robust TBK1 activation when parkin is absent (Extended Data Fig. 3b ). Here, enhanced OPTN(E50K) binding to TBK1 (ref. 19 ) may become advantageous by allowing OPTN phosphorylation by TBK1 in the absence of parkin, thus improving mitophagy. In the absence of TBK1 activation, OPTN is probably not phosphorylated at Ser177 and thus is functionally similar to OPTN(S177A). Notably, the ubiquitin kinase activity of PINK1 is required, as kinase-dead PINK1 did not induce mitophagy ( Table 1 , Fig. 3c and Extended Data Fig. 5g ). Parkin expression markedly increased mitophagy in Flag/HA-OPTN-expressing pentaKO cells (Table 1 and Extended Data Fig.  5h ), supporting the model that PINK1-phosphorylated ubiquitin recruits receptors for mitophagy, and parkin ubiquitination of mitochondrial substrates amplifies this signal.
Comparing mitophagy induced by oligomycin/antimycin A treatment in wild-type relative to PINK1 knockout cells confirmed that endogenous PINK1 mediates mitophagy in the absence of parkin (Extended Data Fig. 6a, b ). Re-expressing PINK1 in PINK1-knockout cells rescued oligomycin/antimycin-A-induced mitophagy (Extended Data Fig. 6c, d ). Furthermore, mCherry-OPTN is recruited to mitochondria in the absence of parkin in a PINK1-dependent manner after prolonged exposure to oligomycin/antimycin A (Extended Data Fig. 6e , f).
Given that PINK1 ubiquitin kinase activity can recruit OPTN and NDP52, we investigated autophagy receptor binding to phosphomimetic (S65D) HA-ubiquitin in HeLa cells. Endogenous OPTN and NDP52 preferentially co-immunoprecipitate with HA-ubiquitin(S65D) (Extended Data Fig. 7a ). Conversely, p62 was present at equal levels in all co-immunoprecipitates (Extended Data Fig. 7a ). Ubiquitin-modified and unmodified forms of OPTN and NDP52 were present in co-immunoprecipitates, and HA-ubiquitin(S65D) induced or preserved this modification (Extended Data Fig. 7a ). Co-immunoprecipitated samples treated with the deubiquitinase USP2 removed the ubiquitin-modified bands on OPTN and NDP52, yet OPTN and NDP52 retained HA-ubiquitin(S65D) binding (Extended Data Fig. 7b ). The binding of endogenous receptors in HeLa cell cytosol to in vitro phosphorylated strep-tactin-tagged ubiquitin (Extended Data Fig. 7c ) showed that OPTN, but not p62, bound better to phospho-ubiquitin (Extended Data Fig. 7d, e ). However, recombinant glutathione S-transferase (GST)-OPTN did not bind better to in vitro phosphorylated Lys63-linked ubiquitin chains 27 , indicating that OPTN may need additional factors or modification in vivo to bind Ser65-phosphorylated ubiquitin preferentially.
OPTN and NDP52 recruit upstream machinery
Autophagy receptors are thought to function primarily by bridging LC3 and ubiquitinated cargo 1,2 . In mCherry-parkin wild-type cells, GFP-LC3B accumulated in distinct puncta adjacent to mitochondria after oligomycin/antimycin A treatment (Extended Data Fig. 8a ). Although oligomycin and antimycin A also induced GFP-LC3B puncta in pentaKOs, they were fewer and not near mitochondria (Extended Data Fig. 8a ). Conversely, GFP-LC3B in ATG5 knockouts was near mitochondria, but not in puncta (Extended Data Fig. 8a ). LC3B lipidation is retained in pentaKOs, but lost in ATG5 knockouts (Extended Data Fig. 8b ). This indicates that ATG5 is activated downstream of PINK1, but independently of autophagy receptors, and that LC3 mitochondrial localization and lipidation are independent steps of mitophagy.
OPTN and NDP52 interact with LC3B and LC3C, respectively, for Salmonella clearance 13, 28 . Beyond that, little is known about the specificity of LC3 family members towards autophagy receptors 29 or their involvement in mitophagy. We examined the recruitment of all LC3 and GABARAP family members to mitochondria in wild-type, pentaKO and NDP52/OPTN DKO cells. The oligomycin/antimycin-A-induced mitochondrial localization of GFP-LC3s in wild-type cells was absent in pentaKO cells, while only GFP-LC3B recruitment was inhibited in NDP52/OPTN DKOs (Fig. 4a and Extended Fig. 8c ). GFP-LC3C recruitment was inhibited in NDP52/ OPTN/TAX1BP1 triple knockouts (Extended Data Fig. 8d, e ), indicating that TAX1BP1 can recruit LC3C during mitophagy. GABARAP proteins did not recruit to mitochondria, indicating that they probably do not have a substantial role in mitophagy (Extended Data Fig. 9a ). We also examined the involvement of WIPI1 and DFCP1, two proteins that mediate phagophore biogenesis upstream of LC3 (ref. 30) , in mitophagy. In wild-type cells, oligomycin/antimycinA-induced foci of both GFP-WIPI1 and GFP-DFCP1, mostly localized on or near mitochondria (Fig. 4b, c and Extended Data Fig. 9b, c) . In NDP52/OPTN DKO cells, GFP-WIPI1 and GFP-DFCP1 foci were reduced, and almost undetectable in pentaKO cells (Fig. 4b, c and Extended Data Fig. 9b, c) . Despite this, the phosphorylation of beclin1 (ref. 31 ) was normal in both pentaKO and NDP52/OPTN DKO cells (Extended Data Fig. 9d ), indicating that failure to recruit WIPI1 and DFPC1 was not due to a defective VPS34 (also known as PIK3C3) complex. GFP-DFCP1 recruitment in pentaKO cells was rescued by the expression of Flag/HA-OPTN or Flag/HA-NDP52, but not by Flag/HA-p62 (Extended Data Fig. 10a ).
Although autophagy receptors are thought to function late in autophagy with LC3 (ref. 32) , the deficit in WIPI1 and DFCP1 recruitment to mitochondria indicates a defect upstream in autophagosome biogenesis. ULK1 phosphorylation by AMPK at Ser317 and dephosphorylation at Ser757 (ref. 33) , required for activation, occurs comparably in wild-type, NDP52/OPTN DKO and pentaKO cells (Fig. 4d ). Despite this, ULK1 puncta appearance 34 after oligomycin and antimycin A treatment is diminished by half in the NDP52/ OPTN DKO cells, and by more than 80% in pentaKO cells (Fig. 4e,  f) . Flag/HA-OPTN or Flag/HA-NDP52, but not Flag/HA-p62, rescued GFP-ULK1 localization in pentaKO cells (Extended Data Fig.  10b ). Overall, these data indicate that NDP52 and OPTN recruit ULK1 to initiate mitophagy.
We next assessed whether ubiquitin phosphorylation, independent of parkin, is also sufficient to recruit ULK1 to mitochondria. Rescue of pentaKO cells expressing FRB-Fis1 and PINK1D110-YFP-23FKBP with Myc-OPTN or Myc-NDP52 resulted in mitochondrial ULK1 puncta after rapalog treatment (Fig. 4g, h) . Myc-OPTN(E50K) also rescued ULK1 recruitment to mitochondria, but mutant Myc-OPTN(Q398X), which is associated with amyotrophic lateral sclerosis, did not ( Fig. 4i and Extended Data Fig. 10d ). ULK1 recruitment was restored by Myc-OPTN(F178A) ( Fig. 4i and Extended Data Fig.  10d ), a mutation that disrupts OPTN association with LC3 (ref. 13) , indicating that ULK1 recruitment is not through LC3 interaction and occurs upstream of LC3 (ref. 34) . Taken together, our data show that PINK1 ubiquitin kinase activity is sufficient to recruit the autophagy receptors and upstream autophagy machinery to mitochondria to induce mitophagy.
Conclusions
Through the genetic knockout of five autophagy receptors, we have defined their relative roles in mitophagy and identified their unanticipated upstream involvement in autophagy recruitment machinery. p62 and NBR1 are dispensable for parkin-mediated mitophagy; OPTN and NDP52 are the primary, yet redundant, receptors. We also uncovered a new and more fundamental role for PINK1 in mitophagy: to induce mitophagy directly through phospho-ubiquitinmediated recruitment of autophagy receptors. We propose that PINK1 generates the novel and essential signature (phospho-ubiquitin) on mitochondria to induce OPTN and NDP52 recruitment and mitophagy; parkin acts to increase this signal by generating more ubiquitin chains on mitochondria, which are subsequently phosphorylated by PINK1. Our findings clarify the role of parkin as an amplifier of the PINK1-generated mitophagy signal, phospho-ubiquitin, which can engage the autophagy receptors to recruit ULK1, DFCP1, WIPI1 and LC3 (see model in Extended Data Fig. 10e ).
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Cell culture, antibodies and reagents. HEK293T, HeLa and PINK1 knockout cells 35 were cultured in DMEM (Life Technologies) supplemented with 10% (v/v) FBS (Gemini Bio Products), 10 mM HEPES (Life Technologies), 1 mM sodium pyruvate (Life Technologies), non-essential amino acids (Life Technologies) and GlutaMAX (Life Technologies). HeLa cells were acquired from the ATCC and authenticated by the Johns Hopkins GRCF Fragment Analysis Facility using STR profiling. All cells were tested for mycoplasma contamination bimonthly using the PlasmoTest kit (InvivoGen). Transfection reagents used were: effectene (Qiagen), lipofectamine LTX (Life Technologies), avalanche-OMNI (EZ Biosystems), X-tremeGENE HP (Roche) and X-tremeGENE 9 (Roche).
The following rabbit monoclonal and polyclonal antibodies were used: beclin, pULK1(S317), pULK1(S757), TBK1, pTBK1(S172), NDP52, TAX1BP1, ATG5, actin, and haemagglutinin (Cell Signaling Technologies); GAPDH and LC3B (Sigma); ULK1 and TOM20 (Santa Cruz Biotechnology); OPTN (Proteintech); GFP (Life Technologies); pSer65 ubiquitin (Millipore) and MFN1 was generated previously 36 . Mouse monoclonal antibodies used were: NBR1 and p62 (Abnova), COXII (Abcam), parkin (Santa Cruz Biotechnology), DNA (Progen Biotechnik) and ubiquitin (Cell Signaling). Chicken anti-GFP (Life Technologies) was also used. For catalogue numbers, see Supplementary Table 1 . Human tissue panel blots were purchased (NOVUS Biologicals). Generation of knockout lines using TALEN and CRISPR/Cas9 gene editing. To generate knockout cell lines, transcription activator-like effector nuclease (TALEN) and CRISPR guide RNAs (gRNAs) were chosen that targeted an exon common to all splicing variants of the gene of interest (listed in Supplementary  Table 1 ). TALEN was used to generate the OPTN knockout HeLa cell line. The TALEN constructs were generated by sequential ligation of coding repeats into pcDNA3.1/Zeo-Talen(163), as previously described [37] [38] [39] . The CRISPR/Cas9 system generated previously 40 was used to knockout ATG5, NDP52, TAX1BP1, NBR1, p62 and TBK1. Oligonucleotides (Operon) containing CRISPR target sequences were annealed and ligated into AlfII-linearized gRNA vector (Addgene 41824) 40 . For CRISPR/Cas9 gene editing, HeLa cells were transfected with gRNA constructs, hCAS9 (Addgene 41815) and pEGFP-C1 (Clontech). For TALEN gene editing, HeLa cells were transfected with OPTN TALEN constructs and pEGFP-C1. Two days after transfection, GFP-positive cells were sorted by FACS and plated in 96-well plates. Single colonies were expanded into 24-well plates before screening for depletion of the targeted gene product by immunoblotting. As a secondary screen of some knockout lines, genomic DNA was isolated from cells and the genomic regions of interest were amplified using PCR followed restriction enzyme digestion analysis (primers listed in Supplementary Table 1 ). Sequencing of targeted genomic regions of knockout lines was also conducted to confirm the presence of frameshifting indels in the genes of interest ( Supplementary Table 1 ). To generate multiple gene knockout cell lines, parental cell lines were transfected sequentially with one or multiple gRNA constructs to generate desired knockout lines. Parental cell lines are outlined in Supplementary Table 1 . Cloning and generation of stable cell lines. pMXs-puro-GFP-WIPI1 and pMXs-puro-GFP-DFCP1 were a gift from N. Mizushima, and pMXs-IP-GFP-ULK1 was purchased from Addgene (38193). To generate pBMN-mEGFP-C1, mEGFP-C1 (Addgene 36412) was PCR amplified (together with the multiple cloning site) and cloned into pBMN-Z at BamHI/SalI sites using the Gibson Cloning kit (New England BioLabs) according to the manufacturer's instructions. The BamHI and SalI sites used to insert mEGFP-C1 were not regenerated. The following GFP-tagged plasmids were generated by PCR amplification of open reading frames followed by ligation into pBMN-mEGFP-C1: OPTN, NDP52, p62, TAX1BP1, NBR1, LC3A, LC3B, LC3C, GABARAP, GABARAPL1 and GABARAPL2. The Gateway Cloning (Invitrogen) system was used to generate GFP-, mCherry-, Myc-and Flag/HA-tagged constructs. In brief, TBK1, TBK1(K38M), NDP52, OPTN, p62, DFCP1, WIPI1 and ULK1 were cloned into pDONR2333. Mutations in complementary DNA sequences were introduced using PCR site-directed mutagenesis in the pDONR2333 vector, (sequences of mutagenesis primers used are available on request) then recombined into pHAGE-N-Flag/HA, pHAGE-N-GFP, pHAGE-N-mCherry and/or pDEST-Nmyc using LR Clonase (Invitrogen) as per the manufacturer's protocol. All constructs generated in this study were verified by sequencing.
To generate stably transfected cell lines, retroviruses (for pBMN-mEGFP-C1 constructs, pBMN-mCherry-parkin, pBMN-puro-P2A-FRB-Fis1, pCHAC-mt-mKeima-IRES-MCS2) and lentiviruses (for pHAGE and pDEST constructs) were packaged in HEK293T cells. HeLa cells were transduced with virus for 24 h with 8 mg ml 21 polybrene (Sigma) then optimized for protein expression via selection (puromycin or blasticidin) or fluorescence sorting. Translocation and mitophagy treatments. Cells were either left untreated or treated with 10 mM oligomycin (Calbiochem), 4 mM antimycin A (Sigma) in fresh growth medium for different periods of time as indicated. Some experiments were performed with 10 mM carbonyl cyanide m-chlorophenyl hydrazine (CCCP) as indicated (Sigma-Aldrich). We chose to use oligomycin/antimycin A to depolarize mitochondria in most of our experiments, as they are specific mitochondrial respiratory complex inhibitors and less toxic. Long treatment time points of both oligomycin/antimycin A and CCCP were also supplemented with the apoptosis inhibitor 20 mM QVD (ApexBio) to prevent cell death. Immunoblotting and phos-tag gels. HeLa cells seeded into six-well plates were either untreated or treated with 10 mM oligomycin (Calbiochem), 4 mM antimycin A (Sigma) and 20 mM QVD (ApexBio) in fresh growth medium for different periods of time as indicated. Cells were lysed in 13 LDS sample buffer (Life Technologies) supplemented with 100 mM dithiothreitol (DTT; Sigma) and heated to 99 uC with shaking for 7-10 min. Approximately 25-50 mg of protein per sample was separated on 4-12% Bis-Tris gels (Life Technologies) according to manufacturer's instructions, and then transferred to polyvinyl difluoride membranes and immunoblotted using antibodies as indicated. To assess mitophagy, COXII quantification was conducted using ImageLab software (BioRad). For uncropped images of all immunoblots, see Supplementary Information.
To dephosphorylate samples, cells were collected as above and lysed in 13 NEB buffer 3 (New England BioLabs) supplemented with 1% Triton X-100 and passed through a 26.5-gauge needle. Calf intestinal phosphatase (CIP; New England BioLabs) was added to half of the cell lysate and the other half was used as an untreated control. Both samples were incubated for 1 h at 37 uC and analysed by SDS-PAGE and immunoblotting.
To analyse beclin phosphorylation, lysates were prepared in sample buffer lacking EDTA and run on 8% Tris-glycine gels containing 20 mM phos-tag (Wako) and 40 mM MnCl 2 as described previously 31 . Gels lacking phos-tag were run simultaneously as a negative control. Electrophoresis and western transfer were carried out using standard protocols with the exception that phos-tag gels were incubated in 10 mM EDTA for 10 min to remove excess Mn 21 before transfer. Immunoprecipitation. Wild-type or PINK1 knockout HeLa cells were transiently transfected with HA-tagged ubiquitin, ubiquitin(S65A) or ubiquitin(S65D) with or without mCherry-parkin for 24 h. Cells were collected, lysed and the HAubiquitin was immunoprecipitated as reported previously 5 , using anti-HA-conjugated beads (Pierce). To deubiquitinate the bound proteins, after binding the HA-ubiquitin, beads were washed three times and incubated in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM DTT and 1.47 mg USP2 (Boston Biochem) at 37 uC for 1 h. The reaction was stopped and the remaining bound proteins were washed five times with 1 ml of buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl), and then eluted by boiling with 13 LDS sample buffer. In vitro phosphorylation. Strep-tagged ubiquitin was incubated with either wild-type or kinase-dead Tribolium castaneum PINK1 (TcPINK1) as previously reported 5 . This ubiquitin was then incubated with cytosol from wild-type HeLa cells in 20 mM HEPES-KOH, pH 7.6, 220 mM mannitol and 70 mM sucrose at 4 uC for 1 h. Strep-tactin beads (Qiagen) were then added to bind the strepubiquitin for an additional 1 h at 4 uC. The ubiquitin and bound proteins were then eluted with 50 mM biotin in 50 mM Tris for 15 min at room temperature. Samples were then diluted in LDS sample buffer before SDS-PAGE and immunoblot analysis. Immunofluorescence microscopy. HeLa cells, seeded in two-well chamber slides (Lab-Tek), were treated as indicated in the figure legends. After treatment, cells were rinsed in PBS and fixed for 15 min at room temperature with 4% paraformaldehyde. Cells were then permeabilized and blocked with 0.1% Triton X-100, 3% goat serum in PBS for 40 min. For immunostaining, cells were incubated with antibodies (as indicated in figure legends) diluted in 3% goat blocking serum overnight at 4 uC, then rinsed with PBS and incubated with either antirabbit or mouse Alexa-Fluor-488-and Alexa-Fluor-633-conjugated secondary antibodies (Life Technologies), or anti-chicken Alexa-Fluor-488-conjugated antibody (Life Technologies) for 1 h at room temperature. Cells were washed three times for 5 min each with 1% Triton X-100 in PBS. During the final wash step, cells were incubated with 10 mg ml 21 DAPI (Sigma) in PBS for 5 min. To measure mitophagy by mtDNA immunostaining, images were obtained from samples stained with DAPI and immunostained for DNA using a plan-Apochromat 633/1.4 oil DIC objective on an LSM 510 microscope (Zeiss). Four image slices were collected through the Z plane encompassing the top and bottom of the cells. Image analysis was performed on all images collected in the Z plane using Volocity software (Perkin Elmer v6.0.1). The percentage of mtDNA stain remaining was calculated using the following formula: (cDNA v 2 nDNA v )/n, in which cDNA v is the total cellular DNA volume determined by staining using anti-DNA antibodies, and nDNA v is the total nuclear DNA stain volume determined using DAPI, and n denotes the number of cells.
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The mtDNA stain volume in untreated cells was normalized to 100% and the amount of mtDNA stain remaining after drug treatment was subsequently determined. Final values represent data acquired from 50-200 cells from three independent experiments, and investigators were not blinded to allocation during image analysis.
To analyse LC3/mitochondrial protein colocalization; cells were treated, fixed and immunostained as above. Between 5 and 8 slices were imaged through the Z plane using either a plan-Apochromat 633 or 1003/1.4 oil DIC objective on a CW STED confocal microscope (Leica). Volocity software (Perkin Elmer, v6.0.1) was used to measure the intensity of the GFP signal representing LC3 in the volume occupied by mitochondria (as defined by the TOM20-positive region) and the cytosol (as defined by TOM20-negative region). 'Normalized mitochondrial LC3' was calculated using the following formula: normalized mitochondrial LC3 5 (m i /m v )/(c i /c v ), in which m i denotes the mitochondrial GFP intensity, m v denotes the mitochondrial volume, c i denotes the cytosolic GFP intensity, and c v denotes the cytosolic volume. The resulting normalized mitochondrial LC3 is equal to 1 if the intensity of GFP is equal per volume in the cytosolic and mitochondrial volumes (no translocation) and is above one if the mitochondrial intensity is higher per volume (translocation). Final values for normalized mitochondrial LC3 represents data acquired from 50 to 105 cells from three independent experiments.
For GFP-DFCP1, GFP-WIPI1 and GFP-ULK1 puncta analysis, cells were treated, prepared and imaged on the CW STED as above with the addition of immunostaining using either rabbit or chicken GFP antibodies to enhance the signal in the green channel. GFP-DFCP1 puncta were quantified using Volocity software (Perkin Elmer v6.0.1) and GFP-WIPI1 and GFP-ULK1 puncta were quantified manually. Investigators were not blinded to allocation during image analysis. Colocalization of autophagy receptors with GFP-DFCP1 or GFP-ULK1 was assessed with line scans using LAS AF software (Leica, v.2.6.0.7266).
Heterodimerization. The C-terminal Fis1 tail of human Fis1 (amino acids 92-152) was cloned into pC4-RhE vector (ARIAD) at SpeI/BamHI sites to make FRB-Fis1 construct, the insert of which was then PCR amplified and cloned into pBMN-Z vector together with Puro-P2A sequence at HindIII, XhoI and NotI sites by an In-Fusion kit from Clontech to make pBMN-puro-P2A-FRB-Fis1. For receptor translocation assays, wild-type HeLa cells stably expressing FRB-Fis1 were generated using retroviral transduction as described above. Previously generated PINK1D110-YFP-23FKBP (ref. 41) wild-type and kinase-dead and individually each mCherry-tagged autophagy receptor were transfected into FRB-Fis1 stable HeLa cells for 24 h. Cells were then treated with 0.5 mM rapalog (Clontech) for 8 h as previously described 41 . Cells were fixed and stained as described above. Cells were manually counted in a blinded manner for translocation of mCherry-tagged autophagy receptors to mitochondria. Final values represent data collected from 100-150 cells for three independent experiments.
For ULK1 and DFCP1 rescue analysis, pentaKO HeLa cells stably expressing FRB-Fis1 were transiently transfected with PINK1D110-YFP-23FKBP, mCherry-ULK1 and one of the autophagy receptors: Myc-OPTN, Myc-NDP52, Myc-OPTN(F178A), Myc-OPTN(E50K) or Myc-OPTN(Q398X) for 18-24 h. Cells were treated with 0.5 mM rapalog or vehicle for 7 h and imaged live on a Zeiss 780 in a humidified 37 uC, 5% CO 2 chamber. To visualize mitochondria in vehicle-treated controls, cells were pre-incubated for 10 min in 75 nM Mitotracker Deep Red (Invitrogen) before imaging. Fields of PINK1-YFP-positive cells were imaged blindly to the mCherry-containing channel. The images were then blinded and counted manually for translocation of mCherry-tagged ULK1 to mitochondria. Final values represent .75 cells counted over at least two independent experiments. Mito-Keima mitophagy assay. mt-mKeima 42 (a gift from A. Miyawaki) was cloned into a pCHAC-MCS-1-IRES-MCS2 vector (Allele Biotechnology). PINK1D110-YFP-23FKBP wild-type and kinase-dead were PCR-amplified from the original pC4M-F2E and cloned into pRetroQ-AcGFP-C1 at NheI/ XhoI sites by Gibson assembly kit. The HA-tag was removed, and stop codon introduced. Wild-type and pentaKO HeLa cells stably expressing FRB-Fis1, mt-mKeima and either wild-type or kinase-dead PINK1D110-YFP-23FKBP were generated using retroviral transduction as described above. Flag/HA-receptors were stably expressed in these cells by lentivirus transduction as described above then treated with 0.5 mM rapalog for 24 h. Cells were then resuspended in sorting buffer (145 mM NaCl, 5 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, 0.1% BSA) containing 10 mg ml 21 DAPI. Analysis was performed using Summit software (v6.2.6.16198) on a Beckman Coulter MoFlo Astrios cell sorter. Measurements of lysosomal mt-mKeima were made using dual-excitation ratiometric pH measurements at 488 (pH 7) and 561 (pH 4) nm lasers with 620/29 nm and 614/20 nm emission filters, respectively. For each sample, 50,000 events were collected and subsequently gated for YFP/mt-mKeima double-positive cells that were DAPI-negative. Data were analysed using FlowJo (v10, Tree Star). Statistical calculations. No statistical methods were used to predetermine sample size, and experiments were not randomized. All statistical data were calculated and graphed using GraphPad Prism 6. To assess statistical significance, data from three or more independent experiments were analysed using one-way ANOVA and Tukey's post-test with a confidence interval of 95%. All error bars are expressed as mean 6 s.d. In Fig. 4h , i, outliers were removed using ROUT in GraphPad Prism 6 with Q 5 1%, and 1-2 values from each condition were removed.
Extended Data Figure 1 | Analysis of knockout cell lines and characterization of autophagy receptor translocation to damaged mitochondria. a, The ATG5 knockout cell line was confirmed by immunoblotting. b, Representative images of mtDNA nucleoids in HeLa cells immunostained with an anti-DNA antibody (green), confirming colocalization with the mitochondrial marker TOM20 (red) (n 5 3 experiments). c, Mitochondrial fractions from mCherry-parkin expressing pentaKO and wild-type cells were assessed by immunoblotting. d, mCh-parkin-expressing wild-type, pentaKO and ATG5 knockouts were treated with oligomycin/ antimycin A with or without MG132. Cell lysates were assessed by immunoblotting. e, Expression levels of GFP-tagged OPTN, NDP52, p62, NBR1 and TAX1BP1 re-expressed in pentaKO cells by immunoblotting. f, Representative images of mCh-parkin-expressing pentaKOs from e immunostained for TOM20 (n 5 3 experiments). g, Expression of GFP-TOLLIP in mCh-parkin pentaKOs. h, PentaKOs mCh-parkin and with or without GFP-TOLLIP expression were immunoblotted. i, Representative images of mCh-parkin pentaKOs expressing GFP-TOLLIP immunostained for TOM20 (n 5 3 experiments). Scale bars, 10 mm.
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Extended Data Figure 3 | TBK1 activates OPTN in PINK1/parkin mitophagy. a, Representative images of untreated mCh-parkin cells and merged images of treated cells as indicated immunostained for DNA. See Fig. 2a for anti-DNA and DAPI images of treated samples (n 5 3). b, Cell lysates from wild-type, NDP52/OPTN DKO, OPTN knockout and NDP52 knockout cells with or without mCh-parkin expression were immunoblotted for TBK1 activation. c, Cell lysates from wild-type and PINK1 knockout cells without parkin expression were immunoblotted for TBK1 activation (S172 phosphorylation). d, Confirmation of TBK1/NDP52 DKO, TBK1/OPTN DKO and TBK1 knockout by immunoblotting. e, Knockout cell lines from d were immunostained for TOM20 (n 5 3). f, Representative images of untreated mCh-parkin wild-type and knockout cells, and merged images of treated cells as indicated were immunostained for DNA. See Fig. 2g for anti-DNA/DAPI images treated samples (n 5 3). g, TBK1/NDP52 DKO cells rescued with GFP-TBK1 wild-type or K38M, or GFP-OPTN(S177D) and were assessed by immunoblotting. h, Cells in g were assessed by immunoblotting. i, Quantification of COXII levels in h displayed as mean 6 s.d. from three independent experiments. **P , 0.005 (one-way ANOVA). Scale bars, 10 mm.
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G2015 Macmillan Publishers Limited. All rights reserved Extended Data Figure 4 | Parkin-independent recruitment of receptors to mitochondria through PINK1 activity. a, Isolated mitochondria from wildtype and pentaKO cells with or without FRB-Fis1 and with wild-type or kinase-dead PINK1D110-YFP-23FKBP were immunoblotted. b-e, Representative images of pentaKO cells expressing FRB-Fis1, wild-type or kinase-dead PINK1D110-YFP-23FKBP, and mCh-OPTN or mCh-NDP52 (b), mCh-p62 (c), mCh-OPTN(D474N) (d) or mCh-NDP52(DZF) (e). Cells were untreated (b) or treated with rapalog (c-e) and immunostained for TOM20. All images are representative of three independent experiments. See Fig. 3b for quantification. Scale bars, 10 mm.
RESEARCH ARTICLE
